Effects of ultraviolet B irradiation on human natural killer cell and lymphokine activated killer cell activity: therapeutic potential in bone marrow transplantation and tumor immunotherapy.
Yaron
I
I
Department of Surgery, Columbia University College of Physicians and Surgeons, New York, NY 10032.
Zakheim
A R
AR
Oluwole
S F
SF
Hardy
M A
MA
D001853:Bone Marrow / Q000276:immunology; D016026:Bone Marrow Transplantation / Q000276:immunology*; D002460:Cell Line; D003602:Cytotoxicity, Immunologic; D005312:Fetal Blood / Q000276:immunology; D006801:Humans; D007376:Interleukin-2 / Q000494:pharmacology; D015979:Killer Cells, Lymphokine-Activated / Q000276:immunology / Q000528:radiation effects*; D007694:Killer Cells, Natural / Q000276:immunology / Q000528:radiation effects*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive; D015473:Leukemia, Promyelocytic, Acute; D008213:Lymphocyte Activation; D011994:Recombinant Proteins / Q000494:pharmacology; D014407:Tumor Cells, Cultured; D014466:Ultraviolet Rays
D007376:Interleukin-2; D011994:Recombinant Proteins